Patent application number | Description | Published |
20140256281 | ALARM SIGNAL CONVERSION FOR TRANSMISSION OVER PACKET-BASED NETWORKS - A computing device is configured to receive an analog alarm signal from an alarm receiving device; convert the analog alarm signal into a packet-based message having information equivalent information as the analog alarm signal; and provide the packet-based message to a server device associated with an alarm monitoring station. The packet-based message may contain information that is used to identify the alarm signal or used to respond to the alarm signal. | 09-11-2014 |
20150030145 | CALLER NAME IDENTIFICATION USING DATA STRUCTURE SYNCHRONIZATION OF DIFFERENT NETWORKS - A device may receive a request to enable service on a wireless network for a user device. The user device may be associated with a wired network. The device may request network provisioning information, associated with the wired network, identifying service activation parameters. The device may provision the wireless network based on the request for network provisioning associated with the wired network. The device may synchronize caller information to a first caller information device, associated with the wireless network, from a second caller information device, associated with the wired network. The caller information may include caller identification information. The device may enable the service for the user device on the wireless network based on provisioning the wireless network and synchronizing the caller information to the first caller information device from the second caller information device. | 01-29-2015 |
20150049865 | LINE SEIZURE IN AN ALARM SYSTEM HAVING AN ALARM SIGNAL PROCESSING DEVICE - A system and method of seizing a landline is disclosed. In seizing the landline, a first device may identify that a switch has been toggled by a second device; receive an alarm signal from the second device via a landline based on identifying that the switch has been toggled; determine a particular processing instruction, of one or more processing instructions, based on information included in the alarm signal; and execute the particular processing instruction to provide the alarm signal to a third device. | 02-19-2015 |
Patent application number | Description | Published |
20090054396 | SUBSTITUTED THIOPHENES AND USES THEREOF - This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical salts, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cancer. | 02-26-2009 |
20090105324 | IMIDAZOLE DERIVATIVES FOR USE AS EDG-1 ANTAGONISTS - The invention relates to chemical compounds of formula (I): or pharmaceutically acceptable salts thereof, which possess Edg-1 antagonistic activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man. | 04-23-2009 |
20090111860 | SULFONAMIDE COMPOUNDS USEFUL AS ADG RECEPTOR MODULATORS - The present invention relates to compounds of formula (I) that mediate Edg, including Edg-1, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment in warm-blooded animals such as humans of diseases that have a significant vascularization or inflammatory component such as in tumor-related diseases. The present invention also relates to compounds that inhibit a5bl, and also that exhibit appropriate selectivity profile(s) against other integrins. | 04-30-2009 |
20100029643 | HETEROCYCLYC SULFONAMIDES HAVING EDG-1 ANTAGONISTIC ACTIVITY - The invention relates to chemical compounds of formula (I), (Ia) and (Ib) or pharmaceutically acceptable salts thereof, which possess Edg-1 antagonistic activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments for use in the production of an anti-cancer effect in a warm-blooded animal, such as man. | 02-04-2010 |
20100197749 | CHEMICAL COMPOUNDS - The invention relates to chemical compounds of formula (I) and (II): | 08-05-2010 |